Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

1,4-Dihydropyridine activators and antagonists: structural and functional distinctions.

D J Triggle, D Rampe

    Trends in Pharmacological Sciences
    |December 1, 1989
    PubMed
    Summary

    Dihydropyridine drugs can activate or block calcium channels, with small structural changes determining their function. Their behavior depends on drug structure and the channel

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Overview of chemical diversity.

    Current protocols in pharmacology·2011
    Same author

    Addiction.

    IDrugs : the investigational drugs journal·2005
    Same author

    Division of Medicinal Chemistry--integrins: past, present and future.

    IDrugs : the investigational drugs journal·2005
    Same author

    Effects of the atrial antiarrhythmic drug AVE0118 on cardiac ion channels.

    Naunyn-Schmiedeberg's archives of pharmacology·2004
    Same author

    Development and evaluation of high throughput functional assay methods for HERG potassium channel.

    Journal of biomolecular screening·2001
    Same author

    Interactions of the antimalarial drug mefloquine with the human cardiac potassium channels KvLQT1/minK and HERG.

    The Journal of pharmacology and experimental therapeutics·2001

    Area of Science:

    • Pharmacology
    • Molecular Biology
    • Biophysics

    Background:

    • Dihydropyridine (DHP) drugs are crucial modulators of calcium (Ca2+) channels.
    • DHPs exhibit diverse activities, acting as both potent antagonists and activators of Ca2+ channels.
    • Subtle structural variations distinguish DHP antagonists from activators.

    Purpose of the Study:

    • To review recent findings on factors influencing DHP drug behavior.
    • To explore the interplay between drug structure and channel activation state.
    • To discuss proposed models for DHP drug mechanism of action.

    Main Methods:

    • Literature review of recent research on dihydropyridine drugs.
    • Analysis of structure-activity relationships for DHP antagonists and activators.

    Related Experiment Videos

  • Discussion of theoretical models for calcium channel modulation.

    • Main Results:

    • Small structural differences in dihydropyridines dictate their function as Ca2+ channel activators or antagonists.
    • DHP activators can paradoxically act as antagonists under conditions of high membrane depolarization.
    • Both the specific drug structure and the channel's activation state are critical determinants of drug efficacy.

    Conclusions:

    • Understanding the nuanced behavior of dihydropyridines is essential for their therapeutic application.
    • Further research into DHP-channel interactions can refine drug design and predict drug responses.
    • Proposed models offer insights into the complex mechanisms governing calcium channel modulation by dihydropyridines.